| View |
|
BRP-040-07
|
Enoxaparin Sodium
|
Sanovince
|
6000 IU Anti-Factor Xa (equivalent to 60 mg) / 0.6 mL
|
Solution For Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
14 September 2021
|
09 December 2025
|
| View |
|
BRP-040-08
|
Enoxaparin Sodium
|
Tamparin
|
6000 IU anti-factor Xa (equivalent to 60 mg) / 0.6 mL
|
Solution For Injection
|
Antithrombotic Agent
|
Brawn Laboratories Limited
|
India
|
Initial [CLIDP]
|
17 September 2021
|
09 December 2025
|
| View |
|
BRP-040-09
|
Enoxaparin
|
Senorin
|
6000 IU Anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (SC)
|
Antithrombotic Agents
|
Brawn Laboratories Limited
|
India
|
-
|
24 September 2021
|
09 December 2025
|
| View |
|
BRP-040-10
|
Enoxaparin sodium
|
Enoxden
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Limited
|
India
|
-
|
26 October 2021
|
09 December 2025
|
| View |
|
BRP-040-11
|
Enoxaparin sodium
|
Isohexane 6000
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
05 November 2021
|
09 December 2025
|
| View |
|
BRP-040-12
|
Enoxaparin Sodium
|
Coranox
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Enoxaparin Sodium
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
05 November 2021
|
09 December 2025
|
| View |
|
BRP-040-13
|
Enoxaparin sodium
|
Noxhart 6000
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
05 November 2021
|
09 December 2025
|
| View |
|
BRP-040-14
|
Enoxaparin Sodium
|
Dynaxaparin
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
05 November 2021
|
09 December 2025
|
| View |
|
BRP-040-15
|
Enoxaparin Sodium
|
Noxaclane
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution For Injection (Sc)
|
Antithrombotic agents
|
Brawn Laboratories Ltd.
|
India
|
Initial (Reconstruction)
|
06 August 2024
|
09 December 2025
|
| View |
|
BRP-040-18
|
Enoxaparin sodium
|
Carcenoxar
|
6000 IU Anti-Factor Xa (Equivalent to 60 mg) / 0.6 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
CLIDP Conversion
|
20 January 2023
|
09 December 2025
|
| View |
|
BRP-041
|
Enoxaparin Sodium
|
Bnoxaparin 40
|
4000 IU Anti-Factor Xa (equivalent to 40mg)/0.4 mL
|
Solution For Injection (Sc)
|
Anticoagulant
|
Brawn Laboratories Ltd.
|
India
|
-
|
01 April 2022
|
09 December 2025
|
| View |
|
BRP-041-01
|
Enoxaparin Sodium
|
Noxadium 4000
|
4000 IU Anti-Factor Xa (equivalent to 40mg)/0.4 mL
|
Solution For Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
13 April 2022
|
09 December 2025
|
| View |
|
BRP-041-02
|
Enoxaparin Sodium
|
Rifoxane
|
4000 IU Anti-Factor Xa (equivalent to 40mg)/0.4 mL
|
Solution For Injection (Sc)
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
13 April 2022
|
09 December 2025
|
| View |
|
BRP-041-03
|
Enoxaparin Sodium
|
Enoxbicare-40
|
4000 IU Anti-Factor Xa (equivalent to 40 mg) / 0.4 mL
|
Solution For Injection (SC)
|
Antithrombotic agents
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation) (Reconstruction)
|
31 July 2024
|
09 December 2025
|
| View |
|
BRP-041-04
|
Enoxaparin sodium
|
Noxprivex
|
4000 IU Anti-Factor Xa (equivalent to 40 mg) / 0.4 mL
|
Solution for Injection (SC)
|
Anticoagulant
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation)
|
25 April 2022
|
09 December 2025
|
| View |
|
BRP-041-05
|
Enoxaparin Sodium
|
Vintrenox
|
4000 IU anti-Factor Xa (equivalent to 40 mg) / 0.4 mL
|
Solution for Injection (SC)
|
Anticoagulant
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation)
|
25 April 2022
|
09 December 2025
|
| View |
|
BRP-041-06
|
Enoxaparin Sodium
|
Goxaparin
|
4000 IU anti-Factor Xa (equivalent to 40 mg) / 0.4 mL
|
Solution for Injection (SC)
|
Anticoagulant
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation)
|
25 April 2022
|
09 December 2025
|
| View |
|
BRP-041-07
|
Enoxaparin Sodium
|
Enoxbasy 40
|
4000 IU Anti-Factor Xa (Equivalent to 40 mg)/ 0.4 mL
|
Solution For Injection (SC)
|
Antithrombotic agents
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation) (Reconstruction)
|
31 July 2024
|
09 December 2025
|
| View |
|
BRP-041-08
|
Enoxaparin sodium
|
Enoxden
|
4000 IU Anti-Factor Xa (Equivalent to 40 mg) / 0.4 mL
|
Solution for Injection (SC)
|
Anticoagulant
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation) (Correction)
|
02 August 2023
|
09 December 2025
|
| View |
|
BRP-041-09
|
Enoxaparin sodium
|
Isohexane 4000
|
4000 IU anti-Factor Xa (equivalent to 40 mg)/0.4 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation)
|
25 April 2022
|
09 December 2025
|